Clinical outcomes of immunotherapy continued beyond radiographic disease progression in older adult patients with advanced non‑small cell lung cancer

Overview of attention for article published in Oncology Letters, May 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 7,870 followers.

RT @esinghimd: 💭 Can older adult patients with advanced non-small cell lung cancer benefit from continuing immunotherapy beyond radiographi…

RT @esinghimd: 💭 Can older adult patients with advanced non-small cell lung cancer benefit from continuing immunotherapy beyond radiographi…

RT @esinghimd: 💭 Can older adult patients with advanced non-small cell lung cancer benefit from continuing immunotherapy beyond radiographi…

RT @esinghimd: 💭 Can older adult patients with advanced non-small cell lung cancer benefit from continuing immunotherapy beyond radiographi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.